Negative Adaptive CRT Trial Yields Useful Clinical Messages

Adaptive resynchronization therapy can benefit patients with heart failure, intact atrioventricular conduction, and left bundle branch block, even though the AdaptResponse trial technically failed.
Medscape Medical News